Home - Products - Others - Other Targets - 1-Methyl-2-(Methylthio)iMidazole

1-Methyl-2-(Methylthio)iMidazole

CAS No. 14486-52-3

1-Methyl-2-(Methylthio)iMidazole( 1-Methyl-2-(Methylthio)iMidazole )

Catalog No. M22194 CAS No. 14486-52-3

1-Methyl-2-(methylthio)imidazole is an impurity of Methimazole, a thiourea antithyroid agent that prevents iodine organification, thus inhibiting the synthesis of thyroxine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Methyl-2-(Methylthio)iMidazole
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Methyl-2-(methylthio)imidazole is an impurity of Methimazole, a thiourea antithyroid agent that prevents iodine organification, thus inhibiting the synthesis of thyroxine.
  • Description
    1-Methyl-2-(methylthio)imidazole is an impurity of Methimazole, a thiourea antithyroid agent that prevents iodine organification, thus inhibiting the synthesis of thyroxine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-Methyl-2-(Methylthio)iMidazole
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    thyroxine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14486-52-3
  • Formula Weight
    128.2
  • Molecular Formula
    C5H8N2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[S]c1nccn1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rongjing S , Hepu L , Yue C , et al. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis[J]. Plos One, 2017, 12(7):e0180108.
molnova catalog
related products
  • Ecliptasaponin A

    Ecliptasaponin A has protective effects against the pulmonary fibrosis induced by bleomycin via reducing the oxidative stress, lung tissue inflammation, and the subsequent epithelial-mesenchymal transition.

  • IDX184

    IDX184 is a potent, orally active, targeted HCV polymerase inhibitor and nucleoside polymerase.IDX184 effectively inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 nM).

  • AdTx1

    Selective, high affinity, non-competitive α1A adrenoceptor antagonist (Ki = 0.35 nM). Exhibits no significant activity against a range of other GPCRs, including α2A, β1 and β2 adrenoceptors. Antagonizes effects of phenylephrine on isolated rabbit prostate muscle in vitro and on intra-urethral pressure in rats.